November 1, 2024

The Pathology of Stargardt Disease and Future Treatment Horizons

By Joseph C. Giacalone, MD, PhD, Brittni A. Scruggs, MD, PhD

October 1, 2024

Clinical Trial Download: The Potential of Optogenetic Therapy

By Yasha Modi, MD , Allen C. Ho, MD, Sulagna Bhattacharya, MBA

October 1, 2024

Anti-VEGF Therapy for Retinopathy of Prematurity

By Vernon S. Volante, BS, Lauren C. Kiryakoza, MD, Hong-Uyen Hua, MD

November 1, 2023

History, Symptoms, and Management of Coats Disease

By Jay K. Rathinavelu, BSE, Grant A. Justin, MD, Lejla Vajzovic, MD, FASRS

November 1, 2023

Clinical Pearls for Pediatric Retinal Detachment

By Seyyedehfatemeh Ghalibafan, MD, Louis Z. Cai, MD, Audina M. Berrocal, MD, et al.

November 1, 2023

Keeping Up With ICROP

By Brittni A. Scruggs, MD, PhD, Reeda Bou Said, MD

November 1, 2023

UPFRONT: New Treatments for Infant Retina Patients

By Peter K. Kaiser, MD

March 1, 2023

Developmental Retinal Vascular Disorders

By Jay K. Rathinavelu, BSE, Lejla Vajzovic, MD, FASRS, Grant A. Justin, MD

October 1, 2022

SUBSPECIALTY NEWS: FDA approves Cimerli, GATHER2 GA trial meets primary endpoint, and more.

By Rochelle Nataloni, contributing writer